Masato Tanabe, Ph.D.

Helix 12 Pharmaceuticals, LLC
email: none

Grants

Novel Enzyme Inhibitors for Estrogen-Dependent Breast Cancer 1997 (Cycle III)
ITaMoCAs 3CB-0188 $364,820